Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1993
12/08/1993CN1079225A Tnf-muteins
12/08/1993CN1079224A Antibiotic compounds
12/08/1993CN1079166A Use of interleukin-10 to suppress graft-VS.-host disease
12/07/1993US5268476 Substituted 10bH-oxazolo[3,2-c] [1,3] benzoxazine-2(3H), 5-diones
12/07/1993US5268455 Process for making biologically active polypeptides based on transforming growth factor-βsequences
12/07/1993US5268454 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
12/07/1993US5268453 Tissue-selective insulin analogs
12/07/1993US5268384 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
12/07/1993US5268361 Hydroxyazido derivatives and related compounds as renin inhibitors
12/07/1993US5268360 Opioid peptides derived from wheat proteins
12/07/1993US5268359 Human tachykinins and their precursor
12/07/1993US5268358 PDGF receptor blocking peptides
12/07/1993US5268296 DNA vector and recombinant host cell for production of hirullin P6 and P18
12/07/1993US5268295 Mammalian adipocyte protein p154, nucleic acids coding therefor and uses thereof
12/07/1993US5268290 Culture product of Streptomyces
12/07/1993US5268277 Method for the preparation of human growth hormone
12/07/1993US5268265 Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV
12/07/1993US5268175 Cosmetic and/or pharmaceutical compositions and methods for their use
12/07/1993US5268169 Intraperitoneally administering
12/07/1993US5268164 Intravascular administering a oligopeptide
12/07/1993CA1324967C Expression and secretion vector in yeasts, useful for preparing heterologous proteins
12/07/1993CA1324954C Inhibition of cell migration with synthetic peptides
12/06/1993EP0608217A4 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition.
12/04/1993CA2097533A1 Peptides having neuroprotective and immunostimulatory functions
12/04/1993CA2097460A1 Angiotensin ii antagonists
12/02/1993CA2097385A1 Promoter for expression and use thereof
12/01/1993EP0572272A1 Absorbable bone sealant
12/01/1993EP0572194A1 Removal of antibodies from blood-derived compositions while retaining coagulation factors
12/01/1993EP0572165A1 New 7B-substituted-4-aza-5a-cholestan-ones as 5a-reductase inhibitors
12/01/1993EP0572122A2 C-terminal modified osteogenic growth polypeptides
12/01/1993EP0572118A1 Monoclonal antibodies to GP130 protein
12/01/1993EP0572110A2 Method of reducing or preventing toxicity associated with antiretroviral therapy by stimulation of the intracellular gluthatione level
12/01/1993EP0571921A2 Cyclopeptides and their use as resorption enhancers in mucous use
12/01/1993EP0571771A2 Method of inactivation of viruses in proteinic preparations
12/01/1993EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993EP0571602A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
12/01/1993EP0571549A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN
12/01/1993EP0571536A1 Reagents and methods for identification of vaccines
12/01/1993EP0571474A1 Orthomolecular method of treating sickle cell disease
12/01/1993EP0571442A1 Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
12/01/1993EP0571417A1 Combination of igf-i and igfbp for anabolism.
12/01/1993EP0571390A1 The delay, prevention and/or reversal of cell senescence
12/01/1993EP0571387A1 A non-mitogenic competitive hgf antagonist
12/01/1993EP0502171A4 Composition for inducing granulocyte production or b cell production in peripheral blood
12/01/1993EP0487591B1 Anticoagulant protein
12/01/1993EP0406324B1 Hematopoietic colony-stimulating factors improve the lipoprotein cholesterol profile
12/01/1993EP0392006B1 Method of making a free-flowing spray-dried edible powder comprising an oil
12/01/1993CN1078910A Biocompatible somatotropin solutions
11/1993
11/30/1993US5266687 Inhibitors of angiogenin
11/30/1993US5266685 Non-bitter protein hydrolyzates
11/30/1993US5266684 Polypeptides
11/30/1993US5266683 Osteogenic proteins
11/30/1993US5266562 Anti-inflammatory agents
11/30/1993US5266561 Treatment of type 2 diabetes mellitus
11/30/1993US5266478 Antibodies which target a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
11/30/1993US5266465 α-1-antichymotrypsin, analogues and methods of production
11/30/1993US5266327 Polyamides
11/30/1993US5266315 Cells or spores and Vancomycin for antidiarrhea agents
11/30/1993US5266312 Asthma, skin disorders
11/30/1993US5266311 Bovine interleukin-1α
11/30/1993US5266310 Stabilization of therapeutically active proteins in pharmaceutical preparations
11/27/1993CA2096889A1 Cyclopeptides and their use as absorption promoters when applied to the mucosa
11/25/1993WO1993023572A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
11/25/1993WO1993023569A1 Method and reagent for inhibiting viral replication
11/25/1993WO1993023557A1 Anti-receptor agents to the vitamin b12/transcobalamin ii receptor
11/25/1993WO1993023556A1 Antibodies to leukemia inhibitory factor
11/25/1993WO1993023549A2 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
11/25/1993WO1993023541A1 Hepatocyte growth factor variants
11/25/1993WO1993023538A1 Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
11/25/1993WO1993023537A1 Chimeric multivalent protein analogues and methods of use thereof
11/25/1993WO1993023526A1 A NOVEL RECEPTOR FOR α4 INTEGRINS AND METHODS BASED THEREON
11/25/1993WO1993023434A2 Bpi-immunoglobulin fusion proteins
11/25/1993WO1993023433A1 Methods and novel proteins associated with low renin syndrome
11/25/1993WO1993023431A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
11/25/1993WO1993023430A1 Brain transcription factors, nucleic acids encoding same and uses thereof
11/25/1993WO1993023429A1 Receptor-type tyrosine kinase-like molecules
11/25/1993WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis
11/25/1993WO1993023426A1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method
11/25/1993WO1993023424A1 Derivatives of dolastatin
11/25/1993WO1993023422A1 Compositions and methods for vaccination against coronaviruses
11/25/1993WO1993023421A1 Universal coronavirus vaccine
11/25/1993WO1993023419A1 NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023403A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
11/25/1993WO1993023379A1 Retroviral protease inhibitors
11/25/1993WO1993023088A1 Biotherapeutic cell-coated microspheres
11/25/1993WO1993023081A1 Methods and agents for modulating immune response, and uses thereof
11/25/1993WO1993023075A1 Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
11/25/1993WO1993023074A1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION
11/25/1993WO1993023073A1 Thyroid peroxidase epitopic regions
11/25/1993WO1993023072A1 Aqueous hexapeptide compositions
11/25/1993WO1993023071A1 Use of igf-1
11/25/1993WO1993023070A1 Use of urodilatin in pulmonary and bronchial diseases
11/25/1993WO1993023069A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/25/1993WO1993023068A1 Platelet derived growth factor antagonists
11/25/1993WO1993023067A1 Igf-1 analogs
11/25/1993WO1993023066A1 Platelet growth promoter
11/25/1993WO1993023065A1 Pharmaceutical compositions containing il-6
11/25/1993WO1993023064A1 Compositions and methods for the prevention and treatment of thrombosis
11/25/1993WO1993023063A1 Novel neutrophil inhibitors
11/25/1993WO1993023062A1 Therapeutic conjugates of toxins and drugs
1 ... 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 ... 3163